Shanghai Hengrui Pharmaceutical Co., Ltd.

This study is testing the safety and effectiveness of a new drug called SHR-A2102 when given with an existing immunotherapy drug (adebrelimab), with or without other cancer therapies. It aims to find the best dose and see if this combination can help control advanced or spreading…

This early-stage trial is testing whether a new drug called SHR-7367, when combined with other cancer medications, is safe and effective for people with advanced solid tumors. The study will enroll about 100 adults to find the best dose and see if the treatment helps shrink tumor…

This study is testing whether a new drug called SHR-7787 works better when combined with other cancer medications for people with advanced solid tumors. Researchers will enroll 400 patients to check if the treatment is safe and if it helps shrink tumors or slow cancer growth. The…

This study is testing whether a new drug called HRS-4642, when combined with other cancer treatments, is safe and can help control advanced pancreatic cancer. It will involve about 60 adults whose cancer has spread and cannot be removed by surgery. The main goal is to see if this…

This clinical trial is testing a new drug called SHR-A1904 for people with advanced solid tumors that have a specific marker called CLDN18.2. The study has two parts: first finding safe doses, then comparing the new drug combinations against standard treatments. Researchers aim t…

This study is testing whether adding a new drug called SHR-A2102 to other cancer treatments before and after surgery helps people with operable non-small cell lung cancer. Researchers want to see if this combination can better eliminate cancer cells and prevent the cancer from co…

This study is testing a new combination of two drugs, SHR-1501 and adbelizumab, for people with advanced or metastatic cancers that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see if the combination can shri…

This early-stage study is testing a new oral medication called HRS-6257 for pain relief. Researchers will give the drug to 80 healthy volunteers to check its safety, how the body processes it, and whether food affects its absorption. The main goal is to see what side effects occu…